ANNAW
AleAnna, Inc. WarrantKey Statistics
About AleAnna, Inc. Warrant
AleAnna, Inc. Warrant (ANNAW) is an innovative biopharmaceutical firm focused on creating transformational therapies for significant unmet medical needs. The company's strategic development includes a strong pipeline of proprietary drug candidates, supported by advanced technologies and collaborative partnerships within the healthcare industry. AleAnna is well-positioned for successful commercialization of its therapeutics, offering institutional investors a promising opportunity for growth in the rapidly evolving biopharmaceutical landscape. With its commitment to enhancing patient outcomes, AleAnna is set to make a notable impact in the healthcare sector.
Fundamentals
| Revenue (TTM) | $39.92M |
| Gross Profit (TTM) | $31.85M |
| EBITDA | $15.76M |
| Operating Margin | 18.70% |
| Return on Equity | 21.60% |
| Return on Assets | 7.33% |
| Revenue/Share (TTM) | $0.98 |
| Book Value | $0.99 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 571.00% |
| Quarterly Revenue Growth (YoY) | 153.50% |
| Shares Outstanding | 0 |
| Float | $10.38M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ANNAW and any ticker you trade — then tracks every position and per-strategy win rate.